drugset / Trial / NCT02856919
A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.
Phase 4
Completed
101 enrolled
Galderma Brasil Ltda.
Eurotrials Brasil Consultores Cientificos Ltda · collab
NaSingle-groupOpen-labelTreatment
Summary
This study evaluates the efficacy of Mirvaso® in the treatment of chronic persistent vascular facial erythema, after 4 weeks of treatment, by the Clinician erythema assessment.
Timeline
- Start
- 2016-06-13
- Primary completion
- 2017-02-08
- Completion
- 2017-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 5 unknown | Topical |
Indications
No indication recorded.